The number of people with susceptibility test result for rifampicin in Lebanon
Lebanon: The number of people with susceptibility test result for rifampicin was 91.2 in 2021. ▬ Flat
Latest (2021)
91.2
Change on year
down 3.8%
World rank
66th
of 146 countries
All-time high
94.78
in 2020
All-time low
89.94
in 2017
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Lebanon, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for the number of people with susceptibility test result for rifampicin in Lebanon is 91.2, measured in 2021.
The figure is down 3.8% on the previous year and up 1.4% over five years.
Lebanon ranks 66th of 146 countries on this measure, in the middle of the range.
The number of people with susceptibility test result for rifampicin in Lebanon, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 89.94 | — |
| 2018 | 93.81 | +4.3% |
| 2019 | 92.89 | -1.0% |
| 2020 | 94.78 | +2.0% |
| 2021 | 91.2 | -3.8% |
Lebanon compared with similar countries
- Lebanon's 91.2 is above the median for lower middle income countries, which is 78.77, 1.2× the median. (32 countries reporting)
- Lebanon's 91.2 is above the median for Middle East, North Africa, Afghanistan & Pakistan, which is 89, 1.0× the median. (15 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 92.21 | 89.94 | 93.81 | 3 |
| 2020s | 92.99 | 91.2 | 94.78 | 2 |
Countries ranked near Lebanon
More health data for Lebanon
- Un projection of annual infant deaths, annual growth rate -2.12 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 1.46 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,106 deaths per 1,000 people (2090)
- Number of infants who die before age 1 185 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate 0.5482 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2024)
- Population ages 00-04, female, per capita 0.038 units per person (2025)
- Population ages 00-04, male, annual growth rate 0.209 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2024)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Lebanon?
- The number of people with susceptibility test result for rifampicin in Lebanon was 91.2 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Lebanon?
- The highest recorded value was 94.78 in 2020.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Lebanon?
- The lowest recorded value was 89.94 in 2017.
- How does Lebanon rank for the number of people with susceptibility test result for rifampicin?
- Lebanon ranks 66th out of 146 countries with data for 2021.
- Where does this Lebanon data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).